NAUT
Nautilus Biotechnology Inc
NASDAQ: NAUT · HEALTHCARE · BIOTECHNOLOGY
$2.50
-3.47% today
Updated 2026-04-29
Market cap
$317.70M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$1 – $4
Volume
0.3M
Nautilus Biotechnology Inc (NAUT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $145.82M | $18.54M | $85.01M | $398.45M | $350.05M | $305.56M | $242.74M |
| Cash & equivalents | $1.20M | $595000.00 | $36.61M | $185.62M | $114.52M | $19.40M | $27.65M |
| Current assets | $1.33M | $16.96M | $77.66M | $349.22M | $187.21M | $176.84M | $132.83M |
| Total liabilities | $140.82M | $490000.00 | $114.73M | $34.87M | $35.13M | $40.21M | $34.01M |
| Current liabilities | $5000.00 | $490000.00 | $3.02M | $5.81M | $6.79M | $9.12M | $7.63M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $5.00M | $18.05M | $-29.72M | $363.58M | $314.92M | $265.35M | $208.73M |
| Retained earnings | $626600.00 | $-14.71M | $-30.32M | $-80.64M | $-138.56M | $-202.24M | $-273.02M |
| Accounts receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |